BD Veritor™ Plus System
for Rapid Detection of RSV

The BD Veritor™ Plus System test for RSV that provides reliable results in 10 minutes.

 

Contact Us

 

BD Veritor All Assays

Simple RSV testing for those at highest risk.

The portable, easy-to-use BD Veritor™ Plus System for Rapid Detection of RSV provides reliable results in 10 minutes.

 

When your pediatric patients need fast, reliable RSV testing, turn to the BD Veritor™ Plus System. Offering reliable results at point of care in a simple-to-operate, handheld instrument.

White and orange packing box with blue lettering for BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 & Flu A+B test

BD Veritor™ Plus System for Rapid Detection of RSV (CLIA-waived kit) offers proven performance

 

PPA†

NPA*

Results in

Compared to viral culture

91.8%

(95% CI: 85.9%, 95.4%)

93.3%

(95% CI: 90.4%, 94.4%)

 

10 minutes

 

Compared to PCR

81.6%

(95% CI: 75.2%, 86.6%)

99.1%

(95% CI: 97.5%, 99.7%)

10 minutes

 

positive percent agreement

negative percent agreement

 

Ordering information

Cat no.

Qty

BD Veritor™ Plus System RSV CLIA-waived kit

256038

30 tests

BD Veritor™ Plus System RSV moderately complex kit

256042

30 tests

BD Veritor™ Plus Analyzer

256066

1 unit

The BD Veritor™ RSV CLIA-waived kit is indicated for use in patients under 6 years of age. The BD Veritor™ RSV moderately complex kit is individual for use in patients under 20 years of age.

Get more answers with every sample.

Content Card Image

Simplifies the testing process

  • Easy operation and single-button functionality may help reduce potential manual errors
  • Provides intuitive sample processing with prefilled, unitized tubes
Content Card Image

Delivers workflow efficiency

Adapts easily to your workflow by offering 2 operational modes

  • Walk Away: the test device is inserted into the Analyzer immediately after preparation, allowing staff to multitask while the sample incubates
  • Analyze Now: the test device is inserted after the incubation time is complete, allowing batches of samples to be tested at once

Option to test the same sample with a BD Veritor™ Flu A+B test device1

Content Card Image

Provides results traceability

  • Downloadable test records matched to kit lot number, operator, patient, or specimen ID with the BD Veritor™ InfoWiFi module or via the companion ImageMover application
  • Offers result printing capabilities via USB port
Content Card Image

Achieves reliable, rapid results

  • Displays easy-to-read digital results for RSV in 10 minutes1
  • Provides clear, objective results by correcting for nonspecific binding and detecting faint lines not recognized by the unaided eye2

Contact a Sales Representative to get your organization’s

diagnostic testing program started today

How It Works

The BD Veritor™ Plus System provides an easy sample-collection process that can be incorporated across a variety of clinical settings.

Content Card Image

Step 1: Collect sample

Content Card Image

Step 2: Mix the swab with the reagent vial

Content Card Image

Step 3: Prepare assay with the sample

Content Card Image

Step 4: Run the test

Content Card Image

Step 5: Insert the cartridge and read the results

BD Veritor™ Plus System Support & Training

See how BD supports you with tools, education, and training—enabling a streamlined point-of-care experience for those you serve, and confidence in your results.

Reimbursement May Be Available Now

Your questions about reimbursement, answered.

1. BD Veritor™ System for Rapid Detection of Respiratory Syncytial Virus (RSV), package insert, 8086098. Franklin Lakes, NJ: Becton, Dickinson and Company BD Life Sciences, 7 Loveton Circle, Sparks, MD 21152-0999 USA 800-638-8663

*EUA Information for the BD Veritor™ SARS-CoV-2 and SARS-CoV-2 & Flu A+B assays: These products have not been FDA cleared or approved; but have been authorized by FDA under EUA for use by authorized laboratories. The BD Veritor™ System for Rapid Detection of SARS-CoV-2 has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; the BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens; and, the emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.